Literature DB >> 33540185

Parkinson's disease after COVID-19.

Karim Makhoul1, Joseph Jankovic2.   

Abstract

Entities:  

Year:  2021        PMID： 33540185     DOI： 10.1016/j.jns.2021.117331

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  13 in total

Review 1.  Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson's Disease: A Narrative Review.

Authors:  Jeremy M Morowitz; Kaylyn B Pogson; Daniel A Roque; Frank C Church
Journal:  Brain Sci       Date:  2022-04-22

Review 2.  Neuroinflammation in Parkinson's Disease - Putative Pathomechanisms and Targets for Disease-Modification.

Authors:  Alexander Grotemeyer; Rhonda Leah McFleder; Jingjing Wu; Jörg Wischhusen; Chi Wang Ip
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

Review 3.  Does Olfactory Dysfunction Correlate with Disease Progression in Parkinson's Disease? A Systematic Review of the Current Literature.

Authors:  Tommaso Ercoli; Carla Masala; Gianluca Cadeddu; Marcello Mario Mascia; Gianni Orofino; Angelo Fabio Gigante; Paolo Solla; Giovanni Defazio; Lorenzo Rocchi
Journal:  Brain Sci       Date:  2022-04-19

4.  SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients.

Authors:  Mauro Morassi; Francesco Palmerini; Stefania Nici; Eugenio Magni; Giordano Savelli; Ugo Paolo Guerra; Matteo Chieregato; Silvia Morbelli; Alberto Vogrig
Journal:  J Neurol       Date:  2021-04-21       Impact factor: 4.849

5.  Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson's disease (PD) do not overlap.

Authors:  Silvia Morbelli; Silvia Chiola; Maria Isabella Donegani; Dario Arnaldi; Matteo Pardini; Raffaele Mancini; Francesco Lanfranchi; Francesca D'amico; Matteo Bauckneht; Alberto Miceli; Erica Biassoni; Beatrice Orso; Emanuela Barisione; Luana Benedetti; Sambuceti Gianmario; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-05       Impact factor: 10.057

6.  Qualitative smell/taste disorders as sequelae of acute COVID-19.

Authors:  Tommaso Ercoli; Carla Masala; Ilenia Pinna; Gianni Orofino; Paolo Solla; Lorenzo Rocchi; Giovanni Defazio
Journal:  Neurol Sci       Date:  2021-09-23       Impact factor: 3.307

Review 7.  SARS-CoV-2, COVID-19 and Parkinson's Disease-Many Issues Need to Be Clarified-A Critical Review.

Authors:  Tsepo Goerttler; Eun-Hae Kwon; Michael Fleischer; Mark Stettner; Lars Tönges; Stephan Klebe
Journal:  Brain Sci       Date:  2022-03-28

8.  COVID-19: The cynosure of rise of Parkinson's disease.

Authors:  Prashanth Lingappa Kukkle
Journal:  Int Rev Neurobiol       Date:  2022-07-22       Impact factor: 4.280

9.  Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism.

Authors:  Valentina Leta; Iro Boura; Daniel J van Wamelen; Mayela Rodriguez-Violante; Angelo Antonini; Kallol Ray Chaudhuri
Journal:  Int Rev Neurobiol       Date:  2022-08-08       Impact factor: 4.280

10.  Parkinsonism as a Sequela of SARS-CoV-2 Infection: Pure Hypoxic Injury or Additional COVID-19-Related Response?

Authors:  Conor Fearon; David J Mikulis; Anthony E Lang
Journal:  Mov Disord       Date:  2021-05-27       Impact factor: 9.698
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.